DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Vincristine (Vincristine) - Hypotension - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Hypotension ()

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Vincristine where reactions include hypotension. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of    Next >>

Possible Vincristine side effects in

Reported by a physician from United States on 2012-08-22

Patient:

Reactions: Abdominal Pain, Thrombosis, Hyperkalaemia, Coagulopathy, Hypoglycaemia, Hypocalcaemia, Hypoxia, Hiccups, Alanine Aminotransferase Abnormal, Pneumonitis, Cough, Pain in Extremity, Hypotension, Hyperglycaemia, External Ear Pain, Haematotoxicity, Dehydration, Lower Gastrointestinal Haemorrhage, Hypofibrinogenaemia, Aspartate Aminotransferase Abnormal, Hypokalaemia, Blood Bilirubin Abnormal, Pleural Effusion, Decreased Appetite, Gamma-Glutamyltransferase Abnormal, Hyponatraemia, Hypercalcaemia, Hypophosphataemia, Diarrhoea, Hypoalbuminaemia, Hypertension, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 10 mg/m2/day divided in to 2 doses for 14 consecutive days
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia

Cytarabine
    Dosage: on day 1 for all patients and on days 8, 15, 22 for cns invlovment
    Indication: Acute Lymphocytic Leukaemia

Methotrexate Sodium
    Dosage: 1 dose on day 15 for no cns involvement and on days 8, 15, 22 for cns involvement
    Indication: Acute Lymphocytic Leukaemia

Hydrocortisone
    Dosage: on days 8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia

Doxorubicin HCL
    Dosage: given over 15-30 minutes on day 1
    Indication: Acute Lymphocytic Leukaemia

Vincristine
    Dosage: 1.5 mg/m2/dose, max. 2 mg, by push on days 1, 8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia

Asparaginase
    Dosage: 2500 units/m2/dose as 4 weekly doses
    Indication: Acute Lymphocytic Leukaemia

Bortezomib
    Dosage: 1.3 mg/sq.m/dose on days 1, 4, 8 and 11 combined with vxld
    Indication: Acute Lymphocytic Leukaemia

Other drugs received by patient: Vancomycin; Posaconazole; Voriconazole; Levofloxacin



Possible Vincristine side effects in male

Reported by a physician from United States on 2012-08-21

Patient: male, weighing 13.6 kg (29.9 pounds)

Reactions: Contusion, Vomiting, Flatulence, Hypotension, Tachycardia, Gastrointestinal Necrosis, Cardio-Respiratory Arrest, Hypophagia, Abdominal Distension, Bacterial Test Positive

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cytarabine
    Dosage: it 2-2.99 yrs 50 mg

Methotrexate Sodium
    Dosage: it 2 mg/m2

PEG-L Asparaginase (Pegaspaegase, Oncospar)
    Dosage: iv 2500 units/m2

Vincristine
    Dosage: iv 1.5mg/m2 on day 1 and day 8

Dexamethasone TAB
    Dosage: po 3 mg/m2 dose (1.75 bid)
    Administration route: Oral



Possible Vincristine side effects in female

Reported by a physician from United States on 2012-08-20

Patient: female, weighing 70.8 kg (155.8 pounds)

Reactions: Abdominal Pain, Hyperpyrexia, Anaphylactic Reaction, Chills, Pain, Hepatic Failure, Transaminases Increased, Splenic Infarction, Loss of Consciousness, Aortic Thrombosis, Off Label Use, Malaise, C-Reactive Protein Increased, Myositis, Dyspnoea, Hypotension, Arrhythmia, Lung Consolidation, Hypophosphataemia, Zygomycosis, Bacteraemia, Ventricular Tachycardia, Hyperammonaemia, Neutropenia, Hepatic Infarction, Shock, Infusion Related Reaction

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Vincristine
    Dosage: day 1,8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2007-10-23
    End date: 2007-10-23

Decadron Phosphate
    Dosage: day 1
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2007-10-23

Velcade
    Dosage: day 1, 4, 8 and 11
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2007-10-23
    End date: 2007-10-23

Cytarabine
    Dosage: day 1,8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2007-10-23

Methotrexate
    Dosage: day 1
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2005-01-01
    End date: 2007-01-01

PEG-Asparaginase
    Dosage: day 2, 8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2007-10-25
    End date: 2007-10-25

Doxil
    Dosage: day 1
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2007-10-23
    End date: 2007-10-23



Possible Vincristine side effects in

Reported by a physician from United States on 2012-08-20

Patient:

Reactions: Abdominal Pain, Thrombosis, Hyperkalaemia, Hypoglycaemia, Coagulopathy, Hypokalaemia, Blood Bilirubin Abnormal, Hiccups, Pleural Effusion, Hypoxia, Hypocalcaemia, Alanine Aminotransferase Abnormal, Cough, Pneumonitis, Decreased Appetite, Pain in Extremity, Hypotension, Hyperglycaemia, Gamma-Glutamyltransferase Abnormal, Hyponatraemia, External Ear Pain, Hypercalcaemia, Haematotoxicity, Hypophosphataemia, Diarrhoea, Dehydration, Hypoalbuminaemia, Lower Gastrointestinal Haemorrhage, Hypertension, Hypofibrinogenaemia, Aspartate Aminotransferase Abnormal, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Bortezomib
    Dosage: 1.3 mg/sq.m/dose on days 1, 4, 8 and 11 combined with vxld
    Indication: Acute Lymphocytic Leukaemia

Vincristine
    Dosage: 1.5 mg/m2/dose, max. 2 mg, by push on days 1, 8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia

Doxorubicin Hydrochloride
    Dosage: given over 15-30 minutes on day 1
    Indication: Acute Lymphocytic Leukaemia

Dexamethasone
    Dosage: 10 mg/m2/day divided in to 2 doses for 14 consecutive days
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia

Cytarabine
    Dosage: on day 1 for all patients and on days 8, 15, 22 for cns invlovment
    Indication: Acute Lymphocytic Leukaemia

Asparaginase
    Dosage: 2500 units/m2/dose as 4 weekly doses
    Indication: Acute Lymphocytic Leukaemia

Hydrocortisone
    Dosage: on days 8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia

Methotrexate
    Dosage: 1 dose on day 15 for no cns involvement and on days 8, 15, 22 for cns involvement
    Indication: Acute Lymphocytic Leukaemia

Other drugs received by patient: Levofloxacin; Voriconazole; Posaconazole; Vancomycin



Possible Vincristine side effects in

Reported by a physician from United States on 2012-08-16

Patient:

Reactions: Off Label Use, Hypotension, Hypertension

Drug(s) suspected as cause:
Cytarabine
    Dosage: on day 1 or days 8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia

Dexamethasone
    Dosage: per day divided into 2 doses was given orally for 14 consecutive days
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia

Methotrexate
    Dosage: on day 15 or days 8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia

Bortezomib
    Dosage: per dose on days 1, 4, 8 and 11
    Indication: Acute Lymphocytic Leukaemia

Vincristine
    Dosage: per dose (2 mg maximum dose) was administered intravenously by push on day 1, 8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia

Hydrocortisone
    Dosage: on days 8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia

Doxorubicin Hydrochloride
    Dosage: over 15-30 minutes on day 1
    Indication: Acute Lymphocytic Leukaemia

PEG-Asparaginase
    Dosage: 2500 units/m2/dose was given intramuscularly as 4 weekly doses
    Indication: Acute Lymphocytic Leukaemia



Possible Vincristine side effects in

Reported by a physician from United States on 2012-08-14

Patient:

Reactions: Thrombosis, Abdominal Pain, Hyperkalaemia, Hypoglycaemia, Coagulopathy, Hypoxia, Hypocalcaemia, Hiccups, Alanine Aminotransferase Abnormal, Cough, Pneumonitis, Pain in Extremity, Hyperglycaemia, Hypotension, External Ear Pain, Haematotoxicity, Dehydration, Lower Gastrointestinal Haemorrhage, Hypofibrinogenaemia, Aspartate Aminotransferase Abnormal, Hypokalaemia, Neuropathy Peripheral, Blood Bilirubin Abnormal, Pleural Effusion, Decreased Appetite, Hyponatraemia, Gamma-Glutamyltransferase Abnormal, Hypercalcaemia, Hypophosphataemia, Diarrhoea, Hypoalbuminaemia, Hypertension, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Vincristine
    Dosage: 1.5 mg/m2/dose, max. 2 mg, by push on days 1, 8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia

Methotrexate
    Dosage: 1 dose on day 15 for no cns involvement and on days 8, 15, 22 for cns involvement
    Indication: Acute Lymphocytic Leukaemia

Bortezomib
    Dosage: 1.3 mg/sq.m/dose on days 1, 4, 8 and 11 combined with vxld
    Indication: Acute Lymphocytic Leukaemia

Doxorubicin Hydrochloride
    Dosage: given over 15-30 minutes on day 1
    Indication: Acute Lymphocytic Leukaemia

Asparaginase
    Dosage: 2500 units/m2/dose as 4 weekly doses
    Indication: Acute Lymphocytic Leukaemia

Cytarabine
    Dosage: on day 1 for all patients and on days 8, 15, 22 for cns invlovment
    Indication: Acute Lymphocytic Leukaemia

Hydrocortisone
    Dosage: on days 8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia

Dexamethasone
    Dosage: 10 mg/m2/day divided in to 2 doses for 14 consecutive days
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia

Other drugs received by patient: Levofloxacin; Vancomycin; Posaconazole; Voriconazole



Possible Vincristine side effects in female

Reported by a physician from United States on 2012-08-14

Patient: female, weighing 70.8 kg (155.8 pounds)

Reactions: Abdominal Pain, Rhabdomyolysis, Hyperpyrexia, Chills, Anaphylactic Reaction, Bone Pain, Hepatic Failure, Transaminases Increased, Loss of Consciousness, Aortic Thrombosis, Splenic Infarction, Hypokalaemia, Malaise, C-Reactive Protein Increased, Dyspnoea, Hypotension, Hypophosphataemia, Zygomycosis, Bacteraemia, Hyperammonaemia, Neutropenia, Hepatic Infarction, Lung Infiltration, Shock, Infusion Related Reaction

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Pegaspargase
    Dosage: unk, unk
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2007-10-25

Vincristine
    Dosage: 2 mg, unk
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2007-10-23
    End date: 2007-10-23

Doxorubicin HCL
    Dosage: 107 mg, unk
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2007-10-23
    End date: 2007-10-23

Cytarabine
    Dosage: 70 mg, unk
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2005-01-01
    End date: 2007-10-23

Methotrexate Sodium
    Dosage: unk, unk
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2005-01-01
    End date: 2007-01-01

Velcade
    Dosage: 1.3 mg/m2, unk
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2007-10-23
    End date: 2007-10-23

Decadron Phosphate
    Dosage: 9 mg, unk
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2007-10-23
    End date: 2007-10-23



Possible Vincristine side effects in

Reported by a physician from United Kingdom on 2012-07-27

Patient:

Reactions: Pneumocystis Jiroveci Pneumonia, Neutropenic Sepsis, Hypotension, Dehydration, Pulmonary Oedema, Psittacosis

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Velcade
    Dosage: 3.3 mg, unk
    Indication: Mantle Cell Lymphoma
    Start date: 2008-05-30
    End date: 2008-09-03

Doxorubicin Hydrochloride
    Dosage: 105 mg, unk
    Indication: Mantle Cell Lymphoma
    Start date: 2008-05-30

Prednisone
    Dosage: 100 mg, unk
    Administration route: Oral
    Indication: Mantle Cell Lymphoma
    Start date: 2008-05-30

Cyclophosphamide
    Dosage: 1600 mg, unk
    Indication: Mantle Cell Lymphoma
    Start date: 2008-05-30

Vincristine
    Dosage: 2 mg, unk
    Indication: Mantle Cell Lymphoma
    Start date: 2008-05-30

Other drugs received by patient: Oramorph SR; Acyclovir; Enoxaparin Sodium; Acyclovir; Acetaminophen; Amitriptyline Hydrochloride; Gabapentin



Possible Vincristine side effects in

Reported by a physician from United Kingdom on 2012-07-17

Patient:

Reactions: Abdominal Pain, Tachycardia, Skin Toxicity, Pyrexia, Fatigue, Neuropathy Peripheral, Hepatotoxicity, Adverse Event, Dizziness, Oedema, Hallucination, Vomiting, Nausea, Gastrointestinal Toxicity, Neutropenic Sepsis, Nephropathy Toxic, Hypotension, Condition Aggravated, Adult T-Cell Lymphoma / Leukaemia, Mucosal Inflammation, Lung Disorder, Infection, Infusion Related Reaction

Adverse event resulted in: death

Drug(s) suspected as cause:
Hydrocortisone
    Indication: Adult T-Cell Lymphoma / Leukaemia

Doxorubicin HCL
    Dosage: on day 1 of 21 day, (cycle 1-5)

Cytarabine
    Indication: Adult T-Cell Lymphoma / Leukaemia

Cyclophosphamide
    Dosage: on day 1 of 21 day cycle, (cycle 1-5)
    Indication: Adult T-Cell Lymphoma / Leukaemia

Zenapax
    Dosage: on days 7 and 14 on cycle 1 of 21 day cycle
    Indication: Adult T-Cell Lymphoma / Leukaemia

Vincristine
    Dosage: (maximum 2 mg) on day 1 of 21 day cycle, (cycle 1-5)
    Indication: Adult T-Cell Lymphoma / Leukaemia

Prednisolone
    Dosage: on days 1-5 of 21 day cycle, (cycle 1-5)
    Administration route: Oral
    Indication: Adult T-Cell Lymphoma / Leukaemia

Methotrexate
    Indication: Adult T-Cell Lymphoma / Leukaemia

Radiotherapy
    Indication: Adult T-Cell Lymphoma / Leukaemia

Doxorubicin HCL
    Dosage: on day 1 of 21 day, (cycle 1-5)
    Indication: Adult T-Cell Lymphoma / Leukaemia

Other drugs received by patient: Acyclovir; Thiabendazole; Cotrim; Itraconazole



Possible Vincristine side effects in male

Reported by a physician from United States on 2012-07-16

Patient: male, weighing 27.7 kg (60.9 pounds)

Reactions: Hypotension, Tachycardia, Respiratory Distress, Heart Rate Decreased, Pulmonary Oedema, Septic Shock, Oxygen Saturation Decreased, Pulseless Electrical Activity

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 78 mg

Methotrexate
    Dosage: 15 mg

PEG-L-Asparaginase (Pegaspargase, Oncospar) 2500 IU
    Dosage: 2500iu

Cytarabine
    Dosage: 70 mg

Vincristine
    Dosage: 3 mg



Possible Vincristine side effects in

Reported by a physician from United Kingdom on 2012-07-10

Patient:

Reactions: Abdominal Pain, Skin Toxicity, Tachycardia, Pyrexia, Fatigue, Neuropathy Peripheral, Hepatotoxicity, Adverse Event, Oedema, Dizziness, Hallucination, Vomiting, Gastrointestinal Toxicity, Nausea, Neutropenic Sepsis, Nephropathy Toxic, Hypotension, Adult T-Cell Lymphoma / Leukaemia, Condition Aggravated, Mucosal Inflammation, Lung Disorder, Infection, Infusion Related Reaction

Adverse event resulted in: death

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: on day 1 of 21 day cycle, (cycle 1-5)
    Indication: Adult T-Cell Lymphoma / Leukaemia

Prednisolone
    Dosage: on days 1-5 of 21 day cycle, (cycle 1-5)
    Administration route: Oral
    Indication: Adult T-Cell Lymphoma / Leukaemia

Cytarabine
    Indication: Adult T-Cell Lymphoma / Leukaemia

Doxorubicin HCL
    Dosage: on day 1 of 21 day, (cycle 1-5)
    Indication: Adult T-Cell Lymphoma / Leukaemia

Vincristine
    Dosage: (maximum 2 mg) on day 1 of 21 day cycle, (cycle 1-5)
    Indication: Adult T-Cell Lymphoma / Leukaemia

Methotrexate
    Indication: Adult T-Cell Lymphoma / Leukaemia

Zenapax
    Dosage: on days 7 and 14 on cycle 1 of 21 day cycle
    Indication: Adult T-Cell Lymphoma / Leukaemia

Hydrocortisone
    Indication: Adult T-Cell Lymphoma / Leukaemia

Radiotherapy
    Indication: Adult T-Cell Lymphoma / Leukaemia

Other drugs received by patient: Cotrim; Itraconazole; Thiabendazole; Acyclovir



Possible Vincristine side effects in

Reported by a health professional (non-physician/pharmacist) from China on 2012-07-02

Patient:

Reactions: Hypotension, Bone Marrow Failure, Rash, Diffuse Large B-Cell Lymphoma, Herpes Zoster, Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Ifosfamide
    Indication: Diffuse Large B-Cell Lymphoma

Daunorubicin HCL
    Indication: Diffuse Large B-Cell Lymphoma

Cisplatin
    Indication: Diffuse Large B-Cell Lymphoma

Bortezomib
    Dosage: at day 8

Etoposide
    Indication: Diffuse Large B-Cell Lymphoma

Vincristine
    Indication: Diffuse Large B-Cell Lymphoma

Doxorubicin Hydrochloride
    Indication: Diffuse Large B-Cell Lymphoma

Cytarabine
    Indication: Diffuse Large B-Cell Lymphoma

Bortezomib
    Dosage: day 1 (12 hr before chemotherapy)
    Indication: Diffuse Large B-Cell Lymphoma

Prednisone
    Indication: Diffuse Large B-Cell Lymphoma

Dexamethasone
    Indication: Diffuse Large B-Cell Lymphoma

Cyclophosphamide
    Indication: Diffuse Large B-Cell Lymphoma

Carboplatin
    Indication: Diffuse Large B-Cell Lymphoma



Possible Vincristine side effects in female

Reported by a physician from Germany on 2012-06-28

Patient: female

Reactions: White Blood Cell Count Decreased, C-Reactive Protein Increased, Sepsis, Hypotension, Presyncope, Neutropenia, Thrombocytopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Vincristine
    Indication: B-Cell Lymphoma
    Start date: 2012-04-26

Cyclophosphamide
    Indication: B-Cell Lymphoma
    Start date: 2012-04-26

Doxorubicin HCL
    Indication: B-Cell Lymphoma
    Start date: 2012-04-26

Mabthera
    Indication: B-Cell Lymphoma
    Start date: 2012-04-25

Neulasta
    Dosage: daily dose 6 mg, 2 x(29 apr 2012+17 may 2012
    Indication: B-Cell Lymphoma
    Start date: 2012-04-29

Prednisolone
    Dosage: frequency 1 times in 2 week for 5 days
    Indication: B-Cell Lymphoma
    Start date: 2012-04-26
    End date: 2012-04-30

Other drugs received by patient: Enoxaparin Natrium; Aspirin; Ramipril; Tiotropium Bromide; Nebivolol; Torsemide; Pantoprazole; Levothyroxine Sodium; Acyclovir; Simvastatin; Trimethoprim + Sulfamethoxazole



Possible Vincristine side effects in 14 year old female

Reported by a physician from United States on 2012-06-28

Patient: 14 year old female, weighing 60.4 kg (132.9 pounds)

Reactions: Stomatitis, Hypotension, Encephalopathy, Acidosis, Hypercalcaemia, Respiratory Failure, Sepsis, Posterior Reversible Encephalopathy Syndrome, Hypocalcaemia, Enterocolitis, Cardiac Arrest

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Ambisome
    Dosage: unk
    Indication: Candida Test Positive
    Start date: 2012-05-20

Dexamethasone Sodium Phosphate
    Dosage: 10 mg/m2, bid or iv on days 1-5 and 15-19
    Administration route: Oral
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-04-30

Mitoxantrone Hydrochloride
    Dosage: 10 mg/m2, over 30 minutes on days 1 and 2
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-04-30

Pegaspargase
    Dosage: 2500 iu/m2 over 1 hr on days 3 and 17
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-04-30

Cefepime
    Dosage: unk
    Indication: Klebsiella Infection
    Start date: 2012-05-10

Vincristine
    Dosage: 1.5 mg/m2 cyclic (max 2 mg) over i-5 minutes or infusion via mini bag on days 1, 8, i5 and 22
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-04-30

Calcium Gluconate

Methotrexate
    Dosage: 8-15 mg (age based dosing) it on days 1 (or up to 72 hours prior to day 1) and 8
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-04-30

Temsirolimus
    Dosage: 7.5 mg/m2, over 30 minutes on days i, 8 and 15 (max dose: 15 mg)
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-04-30



Possible Vincristine side effects in female

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-06-26

Patient: female

Reactions: Syncope, Sepsis, Hypotension, Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 1493 m
    Indication: B-Cell Lymphoma
    Start date: 2012-04-26

Neulasta
    Indication: B-Cell Lymphoma
    Start date: 2012-04-29

Rituximab
    Indication: B-Cell Lymphoma
    Start date: 2012-04-25

Doxorubicin HCL
    Indication: B-Cell Lymphoma
    Start date: 2012-04-26

Prednisolone
    Indication: B-Cell Lymphoma
    Start date: 2012-04-26
    End date: 2012-04-30

Vincristine
    Dosage: 3.94 m
    Indication: B-Cell Lymphoma
    Start date: 2012-04-26

Other drugs received by patient: Simvastatin; Levothyroxine; Ramipril; Acyclovir; Acetylsalicylic Acid SRT; Enoxaparin Sodium; Tiotropium Bromide; Trimethoprim + Sulfamethoxazole; Torsemide; Pantoprazole; Nebivolol



Possible Vincristine side effects in female

Reported by a physician from United Kingdom on 2012-05-29

Patient: female, weighing 46.3 kg (101.9 pounds)

Reactions: Death, Metapneumovirus Infection, Hypotension, Cytomegalovirus Infection, Oxygen Supplementation, Neutropenia, Infection

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 1150 mg, once
    Indication: T-Cell Lymphoma
    Start date: 2011-11-21
    End date: 2012-03-20

Mabcampath
    Dosage: 30 mg, once on day 1 and 3
    Indication: T-Cell Lymphoma
    Start date: 2011-12-07
    End date: 2012-03-22

Vincristine
    Dosage: 2 mg, once
    Indication: T-Cell Lymphoma
    Start date: 2011-11-21
    End date: 2012-03-20

Prednisolone
    Dosage: 100 mg, day 1-5
    Administration route: Oral
    Indication: T-Cell Lymphoma
    Start date: 2011-11-21
    End date: 2012-03-20

Doxorubicin HCL
    Dosage: 75 mg, once
    Indication: T-Cell Lymphoma
    Start date: 2011-11-21
    End date: 2012-03-20

Other drugs received by patient: Lansoprazole; Valganciclovir; Levothyroxine Sodium; Motilium; Lenograstim; Ondansetron; Enoxaparin; Cotrim



Possible Vincristine side effects in 56 year old female

Reported by a individual with unspecified qualification from Germany on 2012-05-17

Patient: 56 year old female

Reactions: Hypotension

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: non-Hodgkin's Lymphoma Unspecified Histology Aggressive

Mabthera
    Indication: non-Hodgkin's Lymphoma Unspecified Histology Aggressive

Vincristine
    Indication: non-Hodgkin's Lymphoma Unspecified Histology Aggressive

Prednisone
    Indication: non-Hodgkin's Lymphoma Unspecified Histology Aggressive

Doxorubicin HCL
    Indication: non-Hodgkin's Lymphoma Unspecified Histology Aggressive



Possible Vincristine side effects in 18 year old male

Reported by a physician from United States on 2012-05-10

Patient: 18 year old male, weighing 126.4 kg (278.1 pounds)

Reactions: Abdominal Pain, White Blood Cell Count Decreased, Hypotension, Hyponatraemia, Acidosis, Capillary Leak Syndrome, Sepsis, Platelet Count Decreased

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Pegaspargase
    Dosage: 2500 iu, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-25
    End date: 2012-03-02

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-24
    End date: 2012-03-02

Vincristine
    Dosage: 2 mg, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-24
    End date: 2012-03-02

Prednisone TAB
    Dosage: 50 mg, bid
    Administration route: Oral
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-24
    End date: 2012-03-04

Methotrexate
    Dosage: unk
    Indication: B Precursor Type Acute Leukaemia

Hydrocortisone
    Dosage: unk
    Indication: B Precursor Type Acute Leukaemia

Cytarabine
    Dosage: 70 mg, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-24

Doxorubicin HCL
    Dosage: 60 mg/m2, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-24
    End date: 2012-02-24



Possible Vincristine side effects in 17 year old male

Reported by a physician from United States on 2012-04-25

Patient: 17 year old male, weighing 45.0 kg (99.0 pounds)

Reactions: Back Pain, Gastrointestinal Haemorrhage, Hypotension, Malnutrition, Neoplasm Progression, Haemorrhoidal Haemorrhage, Convulsion, Leukaemia, Cachexia, Diarrhoea, NO Therapeutic Response, Sepsis, Nervous System Disorder, Altered State of Consciousness

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Methotrexate
    Dosage: ;x1;inth
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-03-05
    End date: 2012-03-05

Methotrexate
    Dosage: ;x1;inth
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-20
    End date: 2012-02-20

Cytarabine
    Dosage: ;x1;inth
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-20
    End date: 2012-02-20

Prednisone
    Dosage: 20 mg/m**2; po
    Administration route: Oral
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-20
    End date: 2012-03-14

Vincristine
    Dosage: 1.5 mg/m**2;x1;iv
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-20
    End date: 2012-02-20

Vincristine
    Dosage: 1.5 mg/m**2;x1;iv
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-03-12
    End date: 2012-03-12

Oncaspar
    Dosage: 2500 iu/m**2;qw;im
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-20
    End date: 2012-03-12

Doxorubicin HCL
    Dosage: 60 ug/m**2;x1;iv
    Indication: B Precursor Type Acute Leukaemia

Velcade
    Dosage: 1.3 mg/m**2;x1;iv
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-20
    End date: 2012-02-20

Other drugs received by patient: Keppra



Possible Vincristine side effects in male

Reported by a physician from United States on 2012-04-13

Patient: male, weighing 63.0 kg (138.7 pounds)

Reactions: Atelectasis, Cardiomegaly, Malaise, Fatigue, Oral Candidiasis, Hypocalcaemia, Pleural Effusion, Dizziness, Pulmonary Oedema, Blood Sodium Decreased, White Blood Cell Count Decreased, Pneumonia, Hypotension, Anaemia, Supraventricular Tachycardia, Toxicity To Various Agents, Lobar Pneumonia, Escherichia Test Positive, Blood Potassium Decreased, Heart Rate Increased, Dehydration, Hypophagia, Platelet Count Decreased, Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Doxorubicin HCL
    Dosage: 50 mg/m2, on day 1 of a 21-day cycle
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2009-01-23
    End date: 2009-03-13

Prednisone TAB
    Dosage: 100 mg, on days 1 through 5 of a 21-day cycle
    Administration route: Oral
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2009-01-23
    End date: 2009-03-13

Rituximab
    Dosage: 375 mg/m2, on day 1 of a 21-day cycle
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2009-01-23
    End date: 2009-03-13

Enzastaurine
    Dosage: 1125 mg, loading dose, on day 2
    Administration route: Oral
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2009-01-24
    End date: 2009-01-24

Vincristine
    Dosage: 1.4 mg/m2, on day 1 of a 21-day cycle
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2009-01-23
    End date: 2009-03-13

Cyclophosphamide
    Dosage: 750 mg/m2, on day 1 of a 21-day cycle
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2009-01-23
    End date: 2009-03-13

Enzastaurine
    Dosage: 500 mg, daily
    Administration route: Oral
    Start date: 2009-01-25
    End date: 2009-03-19

Other drugs received by patient: Hydromorphone; Marinol; Megestrol; Prednisone; Fentanyl; Zofran; Omeprazole; Iron



Possible Vincristine side effects in 18 year old male

Reported by a consumer/non-health professional from United States on 2012-04-13

Patient: 18 year old male, weighing 126.4 kg (278.1 pounds)

Reactions: Abdominal Pain, White Blood Cell Count Decreased, Hypotension, Hyponatraemia, Acidosis, Capillary Leak Syndrome, Sepsis, Platelet Count Decreased

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Vincristine
    Dosage: 2 mg, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-24
    End date: 2012-03-02

Prednisone TAB
    Dosage: 50 mg, bid
    Administration route: Oral
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-24
    End date: 2012-03-04

Hydrocortisone
    Dosage: unk
    Indication: B Precursor Type Acute Leukaemia

Pegaspargase
    Dosage: 2500 iu, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-25
    End date: 2012-03-02

Cytarabine
    Dosage: 70 mg, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-24

Doxorubicin HCL
    Dosage: 60 mg/m2, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-24
    End date: 2012-02-24

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-24
    End date: 2012-03-02

Methotrexate
    Dosage: unk
    Indication: B Precursor Type Acute Leukaemia



Possible Vincristine side effects in 78 year old female

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-04-11

Patient: 78 year old female

Reactions: Hypovolaemic Shock, Dysphagia, Colitis Ulcerative, Haemorrhage, Hypotension, Faeces Discoloured, Abdominal Tenderness, Abdominal Discomfort, Mucosal Ulceration, Fatigue, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Vincristine
    Dosage: 2 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma

Doxorubicin HCL
    Indication: Diffuse Large B-Cell Lymphoma

Rituximab
    Dosage: 375 mg/m2, unk
    Indication: Diffuse Large B-Cell Lymphoma

Cyclophosphamide
    Dosage: 750 mg/m2, unk
    Indication: Diffuse Large B-Cell Lymphoma

Prednisolone
    Indication: Diffuse Large B-Cell Lymphoma



Possible Vincristine side effects in 10 year old female

Reported by a physician from United States on 2012-04-05

Patient: 10 year old female, weighing 20.8 kg (45.8 pounds)

Reactions: Abdominal Pain, Headache, Caecitis, Hypokalaemia, Fungaemia, Hypoxia, Rash Pustular, Back Pain, Nausea, Pain in Extremity, Hypotension, Hyponatraemia, Febrile Neutropenia, Hypophosphataemia, Respiratory Tract Infection, Neuralgia, Enterocolitis Infectious

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Prednisone
    Dosage: 20 mg/m2, cyclic
    Administration route: Oral
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-12-14
    End date: 2011-12-27

Doxorubicin HCL
    Dosage: 60 mg/m2, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-12-14
    End date: 2011-12-14

Cytarabine
    Dosage: unk
    Indication: B Precursor Type Acute Leukaemia
    End date: 2011-12-29

Pegaspargase
    Dosage: unk
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-12-15
    End date: 2011-12-29

Vincristine
    Dosage: 1.5 mg/m2, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-12-14
    End date: 2011-12-29

Methotrexate
    Dosage: unk
    Indication: B Precursor Type Acute Leukaemia
    End date: 2011-12-29

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-12-14
    End date: 2011-12-17

Hydrocortisone
    Dosage: unk
    Indication: B Precursor Type Acute Leukaemia
    End date: 2011-12-29



Possible Vincristine side effects in 78 year old female

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-04-04

Patient: 78 year old female

Reactions: Hypovolaemic Shock, Dysphagia, Colitis Ulcerative, Haemorrhage, Hypotension, Faeces Discoloured, Abdominal Tenderness, Abdominal Discomfort, Mucosal Ulceration, Fatigue, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Doxorubicin HCL
    Indication: Diffuse Large B-Cell Lymphoma

Rituximab
    Dosage: 375 mg/m2, unk
    Indication: Diffuse Large B-Cell Lymphoma

Prednisolone
    Indication: Diffuse Large B-Cell Lymphoma

Vincristine
    Dosage: 2 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma

Cyclophosphamide
    Dosage: 750 mg/m2, unk
    Indication: Diffuse Large B-Cell Lymphoma



Possible Vincristine side effects in 18 year old male

Reported by a physician from United States on 2012-04-03

Patient: 18 year old male, weighing 126.4 kg (278.1 pounds)

Reactions: White Blood Cell Count Decreased, Abdominal Pain, Metabolic Acidosis, Clostridium Test Positive, Urine Output Decreased, Hypotension, Hyponatraemia, Capillary Leak Syndrome, Platelet Count Decreased, Septic Shock

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Oncaspar
    Dosage: 2500 iu;x1;iv
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-02-24
    End date: 2012-03-02

Doxorubicin HCL
    Dosage: 60 mg/m**2;x1;iv
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-02-24
    End date: 2012-02-24

Velcade
    Dosage: 1.3 mg/m**2; qd; iv
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-02-24
    End date: 2012-03-02

Vincristine
    Dosage: 1.5 mg/m**2;qd;iv
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-02-24
    End date: 2012-03-02

Prednisone TAB
    Dosage: 20 mg/m**2;qd;po
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-02-24
    End date: 2012-03-04

Cytarabine
    Dosage: 70 mg;x1;inth
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-02-24

Hydrocortisone
    Indication: Acute Lymphocytic Leukaemia

Methotrexate
    Dosage: inth
    Indication: Acute Lymphocytic Leukaemia



Possible Vincristine side effects in 75 year old male

Reported by a consumer/non-health professional from United States on 2012-03-20

Patient: 75 year old male, weighing 63.0 kg (138.6 pounds)

Reactions: Fatigue, Anaemia, Hypotension, Dehydration, Neutropenia, Lobar Pneumonia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Vincristine
    Dosage: on day 1 every 21 days first dose: 23-jan-09-13mar09(50days)
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2009-03-13
    End date: 2009-03-13

Doxorubicin HCL
    Dosage: on day 1 every 21 days first dose: 23-jan-09-13mar09(50days)
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2009-03-13
    End date: 2009-03-13

Prednisone
    Dosage: on days 1 through 5 every 21 days first dose: 23-jan-09-13mar09(50days)
    Administration route: Oral
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2009-03-13
    End date: 2009-03-13

Enzastaurin
    Dosage: loading dose(1st):1125mg on 24jan09 25jan09-13mar09(48d):500mg;po on hold since 19mar09(54 days)
    Administration route: Oral
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2009-03-19

Cyclophosphamide
    Dosage: on day 1 every 21 days first dose: 23-jan-09-13mar09(50days)
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2009-03-13
    End date: 2009-03-13

Rituximab
    Dosage: on day 1 every 21 days first dose: 23-jan-09-13mar09(50days)
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2009-03-19
    End date: 2009-03-19

Other drugs received by patient: Megestrol Acetate; Zofran; Dronabinol; Fentanyl; Iron; Hydromorphone HCL; Marinol; Omeprazole



Possible Vincristine side effects in male

Reported by a physician from United States on 2012-03-19

Patient: male, weighing 63.0 kg (138.7 pounds)

Reactions: Pneumonia, Fatigue, Hypotension, Dehydration, Anaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Vincristine
    Dosage: 1.4 mg/m2, on day 1 of a 21-day cycle
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2009-01-23
    End date: 2009-03-13

Cyclophosphamide
    Dosage: 750 mg/m2, on day 1 of a 21-day cycle
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2009-01-23
    End date: 2009-03-13

Enzastaurine
    Dosage: 500 mg, daily
    Administration route: Oral
    Start date: 2009-01-25
    End date: 2009-03-19

Rituximab
    Dosage: 375 mg/m2, on day 1 of a 21-day cycle
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2009-01-23
    End date: 2009-03-13

Doxorubicin HCL
    Dosage: 50 mg/m2, on day 1 of a 21-day cycle
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2009-01-23
    End date: 2009-03-13

Enzastaurine
    Dosage: 1125 mg, loading dose, on day 2
    Administration route: Oral
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2009-01-24
    End date: 2009-01-24

Prednisone TAB
    Dosage: 100 mg, on days 1 through 5 of a 21-day cycle
    Administration route: Oral
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2009-01-23
    End date: 2009-03-13

Other drugs received by patient: Fentanyl; Omeprazole; Prednisone; Zofran; Hydromorphone; Megestrol; Iron; Marinol



Possible Vincristine side effects in 18 year old male

Reported by a consumer/non-health professional from United States on 2012-03-13

Patient: 18 year old male, weighing 126.4 kg (278.1 pounds)

Reactions: Abdominal Pain, White Blood Cell Count Decreased, Hypotension, Hyponatraemia, Acidosis, Capillary Leak Syndrome, Sepsis, Platelet Count Decreased

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Doxorubicin HCL
    Dosage: 60 mg/m2, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-24
    End date: 2012-02-24

Vincristine
    Dosage: 1.5 mg/m2, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-24
    End date: 2012-03-02

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-24
    End date: 2012-03-02

Cytarabine
    Dosage: 70 mg, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-24

Pegaspargase
    Dosage: 2500 iu, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-24
    End date: 2012-03-02

Methotrexate
    Dosage: unk
    Indication: B Precursor Type Acute Leukaemia

Prednisone TAB
    Dosage: 20 mg/m2, cyclic
    Administration route: Oral
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-24
    End date: 2012-03-04

Hydrocortisone
    Dosage: unk
    Indication: B Precursor Type Acute Leukaemia



Possible Vincristine side effects in male

Reported by a physician from United States on 2012-03-12

Patient: male, weighing 63.0 kg (138.6 pounds)

Reactions: Atelectasis, Pneumonia, Dyspnoea, Hypotension, Supraventricular Tachycardia, Anaemia, Cardiomegaly, Fatigue, Oral Candidiasis, Dehydration, Heart Rate Increased, Hypocalcaemia, Pleural Effusion, Dizziness, Neutropenia, Escherichia Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Prednisone TAB
    Dosage: 1125 mg
    Administration route: Oral
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2009-01-24
    End date: 2009-01-24

Vincristine
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2009-01-23
    End date: 2009-03-13

Rituximab
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2009-01-23
    End date: 2009-03-13

Doxorubicin HCL
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2009-01-23
    End date: 2009-03-13

Prednisone
    Administration route: Oral
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2009-01-23
    End date: 2009-03-13

Prednisone TAB
    Dosage: 500 mg
    Administration route: Oral
    Start date: 2009-01-25
    End date: 2009-03-19

Cyclophosphamide
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2009-01-23
    End date: 2009-03-13

Other drugs received by patient: Hydromorphone HCL; MD Anderson Mouthwash; Iron; Prednisone; Megestrol Acetate; Omeprazole; Zofran; Fentanyl; Marinol



Possible Vincristine side effects in 10 year old female

Reported by a consumer/non-health professional from United States on 2012-03-09

Patient: 10 year old female, weighing 20.8 kg (45.8 pounds)

Reactions: Abdominal Pain, Confusional State, Lung Infection, Headache, Peripheral Sensory Neuropathy, Caecitis, Hypokalaemia, Fungaemia, Hypoxia, Clostridial Infection, Back Pain, Rash Pustular, Vomiting, Nausea, Pain in Extremity, Lung Neoplasm, Hypotension, Febrile Neutropenia, Pancytopenia, Hyponatraemia, Hypophosphataemia, Diarrhoea, NO Therapeutic Response, Sepsis, Hypophagia, Respiratory Tract Infection, Enterocolitis Infectious, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Pegaspargase
    Dosage: unk
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-12-15
    End date: 2011-12-29

Doxorubicin HCL
    Dosage: 60 mg/m2, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-12-14
    End date: 2011-12-14

Prednisone
    Dosage: 20 mg/m2, cyclic
    Administration route: Oral
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-12-14
    End date: 2011-12-27

Methotrexate
    Dosage: unk
    Indication: B Precursor Type Acute Leukaemia
    End date: 2011-12-29

Vincristine
    Dosage: 1.5 mg/m2, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-12-14
    End date: 2011-12-29

Cytarabine
    Dosage: unk
    Indication: B Precursor Type Acute Leukaemia
    End date: 2011-12-29

Hydrocortisone
    Dosage: unk
    Indication: B Precursor Type Acute Leukaemia
    End date: 2011-12-29

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-12-14
    End date: 2011-12-17



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014